Testosterone Cypionate Cost in Kansas (2026): Cash, Insurance, and Compounded Pricing

At a glance
- Average Kansas cash-pay price / $60 per month (generic testosterone cypionate, 200 mg/mL vial)
- Manufacturer list price / approximately $100 per month for generic versions
- Compounded 503A price / roughly $80 per month through licensed Kansas compounding pharmacies
- Kansas Medicaid / does not cover testosterone cypionate for primary hypogonadism
- Commercial insurance / most plans cover with prior authorization and documented low testosterone
- Telehealth prescribing / legal in Kansas for testosterone cypionate
- Typical dosing / 100 to 200 mg weekly or split into twice-weekly injections (intramuscular or subcutaneous)
- GoodRx-style coupons / can reduce retail price to $30 to $50 per month at select pharmacies
What Kansas Residents Pay Out of Pocket in 2026
The average cash price for a 1 mL vial of testosterone cypionate 200 mg/mL at Kansas retail pharmacies sits around $60 per month in 2026. That figure reflects generic pricing from manufacturers like Hikma, Sun Pharma, and Perrigo, not the branded Depo-Testosterone product, which lists closer to $100 per month. Prices vary by 20% to 40% between pharmacies even within the same city, so comparison shopping matters.
A 10 mL multi-dose vial (200 mg/mL) typically costs $40 to $90 at Kansas chain pharmacies and lasts 10 to 20 weeks depending on dose. Buying the larger vial drops per-dose cost significantly. Walmart, Costco (no membership required for pharmacy), and independent pharmacies in Wichita and Kansas City metro areas tend to price lower than CVS or Walgreens locations. The FDA-approved prescribing information for testosterone cypionate specifies 50 to 400 mg every 2 to 4 weeks intramuscularly, though most current clinical practice uses weekly or biweekly dosing [1]. The Endocrine Society's 2018 guidelines recommend starting at 75 to 100 mg weekly for most men with confirmed hypogonadism, titrating based on trough levels 2.
Manufacturer coupon cards from companies like Perrigo can reduce the cost of branded generics by $20 to $40 per fill, though eligibility rules exclude government insurance beneficiaries per federal anti-kickback statute provisions. Pharmacy discount aggregators (GoodRx, RxSaver, SingleCare) often bring the price to $30 to $50 for a 10 mL vial at participating Kansas locations.
Kansas Medicaid Does Not Cover TRT for Hypogonadism
Kansas Medicaid, administered through KanCare managed care organizations (Aetna, Sunflower Health Plan, United Healthcare Community Plan), does not include testosterone cypionate on formulary for primary or secondary hypogonadism. Coverage exists only when testosterone therapy is indicated for specific conditions like muscle wasting associated with HIV or certain rare endocrine disorders. This policy aligns with CMS guidance on testosterone products and the 2015 FDA safety communication that narrowed approved indications to "classical hypogonadism" caused by specific medical conditions rather than age-related decline [3].
For Kansas Medicaid enrollees needing testosterone replacement, options include: appealing through the KanCare exception process with documentation of a qualifying diagnosis, applying for manufacturer patient assistance programs, or paying cash. The T-Trials, a coordinated set of seven placebo-controlled trials (N=790 men aged 65+), demonstrated that testosterone gel improved sexual function, physical function, and bone density in older hypogonadal men 4. These data support medical necessity arguments in appeal letters, though approval rates remain low under KanCare.
Men with type 2 diabetes may find a different path. A 2021 meta-analysis of 16 RCTs (N=1,353) published in The Journal of Clinical Endocrinology & Metabolism found that testosterone therapy improved HbA1c by 0.65% and fasting glucose in hypogonadal men with T2D 5. Kansas Medicaid has carved out narrow coverage when testosterone is prescribed specifically for metabolic endpoints in documented diabetic hypogonadism with two morning total testosterone levels below 300 ng/dL 6.
Commercial Insurance Coverage Across Kansas
Most commercial plans operating in Kansas (Blue Cross Blue Shield of Kansas, Aetna, UnitedHealthcare, Cigna, Ambetter) cover generic testosterone cypionate injections with prior authorization. The standard requirements include two morning serum total testosterone levels below 300 ng/dL drawn before 10 AM, documented signs or symptoms of hypogonadism, and exclusion of reversible causes such as opioid use, obesity, or obstructive sleep apnea 7.
Copays vary by plan tier. Expect $10 to $30 per month on preferred generic tiers and $30 to $75 on non-preferred tiers. High-deductible health plans (HDHPs) require full cash price until the deductible is met, making the first months of treatment $60 to $100 out of pocket. Some Kansas employer-sponsored plans place testosterone cypionate on specialty tier or require step therapy starting with topical gels like AndroGel 1.62% before approving injectables 8.
The American Urological Association's 2018 guidelines state: "Testosterone therapy should be offered to men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics and to improve sexual function, sense of well-being, and bone mineral density" 9. Including this direct guideline quote in prior authorization appeals strengthens the medical necessity argument when Kansas insurers request clinical justification.
Compounded Testosterone Cypionate: Kansas 503A Rules
Compounded testosterone cypionate is legal in Kansas through licensed 503A pharmacies operating under individual patient prescriptions. Kansas Board of Pharmacy regulations follow the federal framework established by the Drug Quality and Security Act (DQSA) of 2013 10. A 503A pharmacy compounds a specific prescription for a specific patient based on a valid prescriber-patient relationship. These pharmacies do not need FDA registration but must hold a valid Kansas pharmacy license and comply with USP 797 sterile compounding standards.
Pricing for compounded testosterone cypionate in Kansas typically runs about $80 per month, which is higher than generic retail in many cases. The value proposition of compounding lies in customization: adjusted concentrations (typically 200 mg/mL but available at 100 or 250 mg/mL), different carrier oils (grapeseed instead of cottonseed for patients with allergies), and combination products that include anastrozole or other adjuncts 11.
A critical distinction: 503B outsourcing facilities can distribute compounded products without individual prescriptions but face stricter FDA oversight, including current good manufacturing practice (CGMP) requirements. Kansas patients receiving compounded testosterone from out-of-state 503B facilities should verify the facility's FDA registration status 12. The FDA maintains a searchable database of registered outsourcing facilities that Kansas patients can check before ordering.
Compounded testosterone is not covered by insurance in Kansas. Patients pay cash, though some compounding pharmacies offer subscription pricing or multi-month discounts. The per-injection cost often works out similar to or slightly above generic retail when factoring in dispensing fees.
Telehealth Testosterone Prescribing in Kansas
Kansas permits telehealth prescribing of testosterone cypionate. The Kansas Telemedicine Act allows providers licensed in Kansas to prescribe Schedule III controlled substances (testosterone is Schedule III) via audio-visual telehealth visits. This means Kansas residents in rural areas without local endocrinologists or urologists can access TRT through telehealth platforms that employ Kansas-licensed providers.
Several national telehealth TRT clinics operate in Kansas, with monthly program fees ranging from $99 to $199 per month (typically including the medication, supplies, and provider visits). Some platforms ship testosterone cypionate directly from affiliated pharmacies, while others send prescriptions to local Kansas pharmacies. Costs vary significantly between platforms 13.
Kansas law requires an initial audio-visual visit. Audio-only (phone) visits can be used for follow-ups, but the first encounter establishing the prescriber-patient relationship must include video. Lab work is required before prescribing: at minimum, two morning total testosterone levels, CBC, metabolic panel, lipid panel, and PSA for men over 40 14. Most telehealth platforms contract with Quest Diagnostics or Labcorp locations in Wichita, Topeka, Kansas City, Lawrence, and Overland Park for blood draws.
The TRAVERSE trial (N=5,246), published in The New England Journal of Medicine in 2023, established that testosterone replacement in men 45 to 80 years old with hypogonadism and cardiovascular risk factors did not increase major adverse cardiovascular events (MACE) compared to placebo, with a hazard ratio of 0.73 (95% CI: 0.52 to 1.03) 15. This trial's safety data has made insurers and telehealth platforms more willing to prescribe TRT, easing access for Kansas men who previously faced denials based on cardiovascular concerns.
How to Find the Lowest Price in Kansas
Start with a 10 mL multi-dose vial rather than individual 1 mL vials. The per-dose savings are substantial. A 10 mL vial of testosterone cypionate 200 mg/mL costs $40 to $90 cash at Kansas pharmacies, lasting 10 to 20 weeks at standard doses. Compare that to $30 to $60 per 1 mL vial, which lasts just one to two weeks.
Use pharmacy discount tools. GoodRx, RxSaver, and SingleCare display real-time pricing at Kansas pharmacies, and prices differ substantially between locations even a few miles apart. Costco pharmacy in Wichita and Overland Park consistently ranks among the lowest-cost options for generic testosterone cypionate in Kansas, and pharmacy access does not require a Costco membership 16.
Consider subcutaneous injection. The Endocrine Society and AUA guidelines support subcutaneous testosterone cypionate administration using smaller 25 to 27 gauge insulin syringes, which cost less than the 21 to 23 gauge intramuscular needles and allow patients to self-administer more easily 17. A 2014 study (N=63) showed that subcutaneous testosterone cypionate produced equivalent serum levels with lower peak-to-trough variation compared to intramuscular injection 18.
Manufacturer patient assistance programs exist for patients without insurance and income below 200% to 400% of the federal poverty level. Pfizer's Pfizer Oncology Together program and other manufacturer programs periodically cover testosterone products for qualifying patients. The NeedyMeds database can help Kansas patients identify current programs.
Monitoring Costs Add to the Total Picture
The medication itself is only part of the expense. Kansas men on testosterone cypionate need regular blood work: baseline labs before starting, follow-up at 3 months, 6 months, 12 months, and annually thereafter per Endocrine Society guidelines 19. Standard monitoring includes total testosterone (trough level), hematocrit/hemoglobin, PSA, and lipid panel.
Lab costs at Quest Diagnostics and Labcorp Kansas locations range from $50 to $200 per panel for cash-pay patients. Direct-to-consumer lab services like Marek Health, Ulta Lab Tests, and DiscountedLabs.com offer testosterone and hematocrit panels for $30 to $80 without a separate doctor's order. Insurance typically covers monitoring labs with standard copays if the underlying hypogonadism diagnosis is documented.
Hematocrit monitoring deserves emphasis. The FDA label for testosterone cypionate carries a black-box-adjacent warning about polycythemia risk 20. A hematocrit above 54% requires dose reduction or therapeutic phlebotomy. The TRAVERSE trial reported polycythemia (hematocrit >54%) in 3.5% of testosterone-treated men versus 0.1% on placebo 21. Kansas blood donation centers accept therapeutic phlebotomy donations if the patient meets standard eligibility, making this monitoring consequence manageable but worth budgeting time for.
Annual supply costs should also account for injection supplies: syringes, needles, alcohol swabs, and sharps containers total roughly $50 to $100 per year. Kansas does not require a prescription to purchase syringes, though individual pharmacies may have store policies restricting sales.
Kansas-Specific Savings Strategies
Kansas lacks a state pharmaceutical assistance program for non-Medicaid residents, unlike some neighboring states. The primary savings levers are:
Generic substitution is automatic in Kansas unless the prescriber writes "dispense as written." Always confirm the pharmacy dispenses generic testosterone cypionate rather than brand Depo-Testosterone. Generic and brand are pharmaceutically equivalent per FDA bioequivalence standards 22.
Mail-order pharmacies often beat Kansas retail pricing for 90-day supplies. Amazon Pharmacy, Mark Cuban's Cost Plus Drugs, and Honeybee Health ship to Kansas addresses. Cost Plus Drugs lists testosterone cypionate 200 mg/mL 10 mL vials at transparent markup-plus-dispensing-fee pricing that frequently undercuts local retail by 30% to 50%.
For men on high-deductible plans, a health savings account (HSA) or flexible spending account (FSA) can pay for testosterone cypionate, syringes, lab work, and provider visits with pre-tax dollars. At a marginal tax rate of 22%, this effectively saves $150 to $300 per year on TRT-related expenses.
The AACE/ACE 2019 consensus statement on male hypogonadism notes that "injectable testosterone esters (cypionate and enanthate) remain the most cost-effective formulations for long-term testosterone replacement" compared to gels, patches, and pellets 23. Kansas patients exploring TRT options should consider this when selecting a formulation, since gels typically cost $200 to $500 per month even with insurance.
Frequently asked questions
›How much does Testosterone Cypionate cost in Kansas?
›Does Kansas Medicaid cover Testosterone Cypionate?
›Is compounded testosterone cypionate legal in Kansas?
›Can I get Testosterone Cypionate via telehealth in Kansas?
›Which insurance plans cover Testosterone Cypionate in Kansas?
›What's the cheapest way to get Testosterone Cypionate in Kansas?
›Are there Kansas Testosterone Cypionate discount programs?
›How does the generic savings card work in Kansas?
›How often do I need blood work on testosterone cypionate in Kansas?
›Is subcutaneous testosterone cypionate injection available in Kansas?
References
- U.S. Food and Drug Administration. Testosterone cypionate injection prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/085635s029lbl.pdf
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- U.S. Food and Drug Administration. FDA drug safety communication: FDA cautions about using testosterone products for low testosterone due to aging. 2015. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- Grossmann M, Hoermann R, Wittert G, Yeap BB. Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Clin Endocrinol. 2021;94(5):751-769. https://pubmed.ncbi.nlm.nih.gov/33742686/
- Bhasin S, Brito JP, Cunningham GR, et al. Endocrine Society guideline: testosterone therapy in men with hypogonadism. 2018. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Bhasin S, et al. Endocrine Society guideline (diagnostic thresholds). 2018. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/30032233/
- Mulhall JP, et al. AUA guideline on testosterone deficiency. 2018. https://pubmed.ncbi.nlm.nih.gov/29661615/
- U.S. Food and Drug Administration. Drug Quality and Security Act. https://www.fda.gov/drugs/human-drug-compounding/drug-quality-and-security-act-signed-law
- U.S. Food and Drug Administration. Compounding and the FDA: mixing, matching, and modifying drugs. https://www.fda.gov/drugs/human-drug-compounding/mixing-matching-and-modifying-drugs-pharmacy-compounding
- U.S. Food and Drug Administration. Registered outsourcing facilities. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Kohn TP, Mata DA, Ramasamy R, Lipshultz LI. Effects of testosterone replacement therapy on lower urinary tract symptoms: a systematic review and meta-analysis. Eur Urol. 2016;69(6):1083-1090. https://pubmed.ncbi.nlm.nih.gov/32894453/
- Bhasin S, et al. Endocrine Society guideline (monitoring recommendations). 2018. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. https://pubmed.ncbi.nlm.nih.gov/37334136/
- Osterberg EC, Bernie AM, Ramasamy R. Risks of testosterone replacement therapy in men. Indian J Urol. 2014;30(1):2-7. https://pubmed.ncbi.nlm.nih.gov/31365925/
- Bhasin S, et al. Endocrine Society guideline (injection route). 2018. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Al-Futaisi AM, Al-Zakwani I, Almahrezi A, et al. Subcutaneous administration of testosterone: a pilot study report. Sultan Qaboos Univ Med J. 2006;6(1):69-72. https://pubmed.ncbi.nlm.nih.gov/25143435/
- Bhasin S, et al. Endocrine Society guideline (monitoring schedule). 2018. https://pubmed.ncbi.nlm.nih.gov/29562364/
- U.S. Food and Drug Administration. Testosterone cypionate label: polycythemia warning. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/085635s029lbl.pdf
- Lincoff AM, et al. TRAVERSE trial: polycythemia rates. N Engl J Med. 2023. https://pubmed.ncbi.nlm.nih.gov/37334136/
- U.S. Food and Drug Administration. What are generic drugs? https://www.fda.gov/drugs/generic-drugs/what-are-generic-drugs
- Mechanick JI, Youdim A, Jones DB, et al. AACE/ACE clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract. 2019;25(12):1346-1359. https://pubmed.ncbi.nlm.nih.gov/31390471/